Treatment of neutropenia-related fungal infections with granulocyte colony-stimulating factor-elicited white blood cell transfusions: A pilot study

Leukemia

Volumn 11, Issue 10, 1997, Pages 1621-1630

  Dignani, M C ^a   Anaissie, E J ^b,f   Hester, J P ^c   O'Brien, S ^d   Vartivarian, S E ^d   Rex, J H ^e   Kantarjian, H ^d   Jendiroba, D B ^d   Lichtiger, B ^d   Andersson, B S ^d   Freireich, E J ^d  

^a Infectious Diseases Hospital   (Argentina)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c Haemapheresis Department   (United States)

^d UNIVERSITY OF TEXAS   (United States)

^e NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^f UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Fungal infections; Granulocyte colony stimulating factor (G CSF); Granulocyte transfusion; Leukemia; Pneumonia

Indexed keywords

AMPHOTERICIN B; ANTINEOPLASTIC AGENT; GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; AGED; ARTHRALGIA; ARTICLE; CLINICAL ARTICLE; FEMALE; GRANULOCYTE TRANSFUSION; HUMAN; HUMAN CELL; LEUKOCYTE COUNT; LEUKOCYTE TRANSFUSION; MALE; MYALGIA; MYCOSIS; NEUTROPENIA; NEUTROPHIL; PRIORITY JOURNAL; PROSPECTIVE STUDY; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 16944364533     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2400811     Document Type: Article

References (24)

1. Anaissie E, Kontoyiannis DP, Vartivarian S et al. Effectiveness of an oral triazole for opportunistic mold infections in cancer patients: experience with SCH 39304. Clin Infect Dis 1993; 17: 1022-1031.
2. Koza I, Holland J, Cohen E. Histocompatible leukocyte transfusion during granulocytopenia. Neoplasma 1971; 18: 185-191.
3. Graw RG, Herzig G, Perry S, Henderson E. Normal granulocyte transfusion therapy: treatment of septicemia due to gram-negative bacteria. New Engl J Med 1972; 287: 367-371.
4. McCredie K, Freireich E, Hester J, Vallejos C. Leukocyte transfusion therapy for patients with host-defense failure. Transplant Proc 1973; V: 1285-1289.
5. Alavi JB, Root RK, Djerassi I et al. Randomized clinical trial of granulocyte transfusions for infection in acute leukemia. New Engl J Med 1977; 296: 701-705.
6. Higby DJ, Yates JW, Henderson ES, Holland JF. Filtration leukapheresis for granulocyte transfusion therapy: clinical and laboratory studies. New Engl J Med 1975; 292: 761-766.
7. Fortuny IE, Bloomfield CD, Hadlock DC, Goldman A, Kennedy BJ, McCullough JJ. Granulocyte transfusion: a controlled study in patients with acute nonlymphocytic leukemia. Transfusion 1975; 15: 548-558.
8. Higby DJ, Freeman A, Henderson ES, Sinks L, Cohen E. Granulocyte transfusions in children using filter-collected cells. Cancer 1976; 38: 1407-1413.
9. Herzig RH, Herzig GP, Graw RG, Bull M, Ray KK. Successful granulocyte transfusion therapy for gram-negative septicemia. New Engl J Med 1977; 296: 701-705.
10. Vogler WR, Winton EF. A controlled study of the efficacy of granulocyte transfusions in patients with neutropenia. Am J Med 1977; 63: 548-555.
11. Aisner J, Schiffer C, Wiernik P. Granulocyte transfusions: evaluation of factors influencing results and a comparison of filtration and intermittent centrifugation leukapheresis. Br J Haematol 1978; 38: 121-129.
12. Winston DJ, Ho WG, Gale RP. Therapeutic granulocyte transfusions for documented infections: a controlled trial in ninety-five infectious granulocytopenic episodes. Ann Intern Med 1982; 97: 509-515.
13. Bhatia S, McCullough J, Perry EH, Clay M, Ramsay NKC, Neglia JP. Granulocyte transfusions: efficacy in treating fungal infections in neutropenic patients following bone marrow transplantation. Transfusion 1994; 34: 226-232.
14. Applebaum F, Bowles C, Makuch R, Deisseroth A. Granulocyte transfusion therapy of experimental Pseudomonas septicemia: study of cell dose and collection technique. Blood 1978: 52: 323-331.
15. Freireich EJ, Levin RH, Whang J, Carbone PP, Bronson W, Morse EE. The function and fate of transfused leukocytes from donors with chronic myelocytic leukemia in leukopenic recipients. Ann NY Acad Sci 1965; 113: 1081-1087.
16. Hollingshead LM, Goa KL. Recombinant granulocyte colony-stimulating factor: a review of its pharmacological properties and prospective role in neutropenic conditions. Drugs 1991; 42: 300-330.
17. Bensinger WI, Price TH, Dale DC et al. The effects of daily recombinant human granulocyte-colony stimulating factor administration on normal granulocyte donors undergoing leukapheresis. Blood 1993; 81: 1883-1888.
18. Lieschke GJ, Burgess AW. Granulocyte-colony stimulating factor and granulocyte-macrophage colony stimulating factor (first of two parts). New Engl J Med 1992; 327: 28-35.
19. Colotta F, Re F, Polentarutti N, Sozzani S, Mantovani A. Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood 1992; 80: 2012-2020.
20. Schiffer CA. Transfusion support. Hematol Oncol Ann 1994; 2: 277-279.
21. Cabrilove JL, Jakubowski A, Fain K et al. Phase I study of granulocyte-colony stimulating factor in patients with transitional cell carcinoma of the urothelium. J Clin Invest 1988; 82: 1454-1461.
22. Albelda S, Talbot G, Gerson S, Miller W, Cassileth P. Pulmonary cavitation and massive hemoptysis in invasive pulmonary aspcrgillosis. Am Rev Respir Dis 1985; 131: 115-120.
23. Nelson P, Dignani M, Anaissie E. Taxonomy, biology, and clinical aspects of Fusarium species. Clin Microbiol Rev 1994; 7: 479-504.
24. Maksymiuk AW, Thongprasert S, Hopfer R, Luna M, Fainstein V, Bodey GP. Systemic candidiasis in cancer patients. Am J Med 1984; 77:20-27.